Sort
261,768 grants matching “gene therapy”
Systems Approaches to Novel Molecular Mechanism in Alzheimer's Disease
$2,531,701Gang Yu · Ut Southwestern Medical Center · RF1 · FY2024 · AG
Functional analysis of glia in tauopathy
$2,531,613Mel B Feany · Brigham And Women'S Hospital · RF1 · FY2022 · AG
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
$2,531,125Lishomwa C Ndhlovu · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,690Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,530,688Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA
CONSOLIDATED BASIC CANCER RESEARCH PROGRAM
$2,530,470Wistar Institute · P30 · FY2005 · CA
Cellular Control: Synthetic Signaling/Motility (RMI)
$2,530,000Wendell A Lim · University Of California, San Francisco · PN2 · FY2010 · EY
Clinical Epidemiology and Pathogenesis of Asymptomatic HSV
$2,529,656Anna Wald · University Of Washington · P01 · FY2015 · AI
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,529,095Paula M Cannon · University Of Southern California · U19 · FY2019 · HL
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,529,095Paula M Cannon · University Of Southern California · U19 · FY2018 · HL
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
$2,529,082Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2019 · HL
Transplant Tolerance in Non-Human Primates
$2,528,893Christian P Larsen · Emory University · U19 · FY2020 · AI
Transplant Tolerance in Non-Human Primates
$2,528,893Christian P Larsen · Emory University · U19 · FY2021 · AI
Transplant Tolerance in Non-Human Primates
$2,528,893Christian P Larsen · Emory University · U19 · FY2019 · AI
DCTD Screening Technologies
$2,528,434David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Preclinical drug development in pancreatic cancer
$2,528,211Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,527,492Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
LICI Microbiome and Genetics Core
$2,525,817Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,525,060Christopher K Glass · University Of California, San Diego · P01 · FY2021 · HL
The Cellular Geography of Therapeutic Resistance in Cancer
$2,524,826Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2019 · CA
The Cellular Geography of Therapeutic Resistance in Cancer
$2,524,826Eliezer M Van Allen · Dana-Farber Cancer Inst · U2C · FY2022 · CA
The Cellular Geography of Therapeutic Resistance in Cancer
$2,524,824Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2020 · CA
URoL: Epigenetics 2: Learning the rules of dynamic epigenetic regulation
$2,524,657Georg Seelig · University Of Washington · · FY2020 · BIO
Understanding Papillomavirus Virion Proteins and Vaccines
$2,524,474John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Breast and Other Cancers in the California Teachers Cohort
$2,524,331Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2011 · CA